News

Yahoo Finance14d
Caris Life Sciences indicated to open at $30, IPO priced at $21 per share - Yahoo Finance
Caris Life Sciences (CAI) priced 23.53M shares at $21.00. The deal priced above the $19.00-$20.00 range. BofA, JPMorgan and Goldman Sachs acted as joint book running managers for the offering.
Yahoo Finance2mon
Caris Life Sciences Raises $168 Million in Private Capital from Leading Investors to Continue Platform Expansion - Yahoo Finance
Caris Life Sciences® (Caris), a leading next-generation AI TechBio company and precision medicine pioneer, announced today that the company has closed a growth capital funding round of $168 million.
FierceBiotech4y
Caris Life Sciences scores $830M to grow AI-powered genetic sequencing platform - Fierce Biotech
Before its two most recent rounds, Caris snagged $150 million in debt financing in October 2018 from Sixth Street, which also contributed an additional $75 million in debt financing to the 2020 round.
Morningstar2mon
Caris Life Sciences Raises $168 Million in Private Capital from Leading Investors to Continue Platform Expansion - Morningstar
IRVING, Texas, April 7, 2025 /PRNewswire/ -- Caris Life Sciences® (Caris), a leading next-generation AI TechBio company and precision medicine pioneer, announced today that the company has closed ...